Edition:
India

Catalyst Pharmaceuticals Inc (CPRX.OQ)

CPRX.OQ on NASDAQ Stock Exchange Capital Market

6.51USD
10:04pm IST
Change (% chg)

$-0.05 (-0.69%)
Prev Close
$6.56
Open
$6.56
Day's High
$6.74
Day's Low
$6.51
Volume
270,741
Avg. Vol
471,768
52-wk High
$7.67
52-wk Low
$1.85

Select another date:

Wed, Jun 12 2019

Catalyst Pharma sues FDA over approval of cheaper rival drug

Catalyst Pharmaceuticals Inc, which has come under fire for the high price tag on its rare disease drug, on Wednesday sued the U.S. Food and Drug Administration to challenge the recent approval of a lower-cost rival drug.

UPDATE 2-Catalyst Pharma sues FDA over approval of cheaper rival drug

June 12 Catalyst Pharmaceuticals Inc, which has come under fire for the high price tag on its rare disease drug, on Wednesday sued the U.S. Food and Drug Administration to challenge the recent approval of a lower-cost rival drug.

Catalyst Pharma files lawsuit against U.S. FDA on Jacobus Pharma drug approval

June 12 Catalyst Pharmaceuticals Inc said on Wednesday it has filed a lawsuit against the U.S. Food and Drug Administration, challenging the recent approval of Jacobus Pharmaceutical Co's drug, Ruzurgi, for a rare neuromuscular disease.

Select another date: